DEVELOPMENT OF REPERFUSION THERAPY FOR ISCHEMIC STROKE IN THE RUSSIAN FEDERATION: ACHIEVEMENTS AND PROSPECTS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Ischemic stroke occupies a leading position in the structure of acute cerebrovacular disorders and is a significant problem due to high rates of incidence, mortality and disability. Given the high effectiveness of reperfusion therapy in comparison with other treatments in the acute period of stroke, and also on the basis of pharmacoeconomic data, considerable efforts are now being made to increase the number of patients, in which particular method of reperfusion can be used.

Full Text

Restricted Access

About the authors

N. A Shamalov

SRI of Cerebrovascular Pathology and Stroke FSBEI HE RNSMU n.a. N.I. Pirogov of RMH

Email: shamalovn@gmail.com
MD, Prof. at the Department of Fundamental and Clinical Neurology and Neurosurgery, Head of the Department of Treatment and Diagnosis of Stroke

L. V Stakhovskaya

SRI of Cerebrovascular Pathology and Stroke FSBEI HE RNSMU n.a. N.I. Pirogov of RMH

M. A Tikhonova

SRI of Cerebrovascular Pathology and Stroke FSBEI HE RNSMU n.a. N.I. Pirogov of RMH

K. V Anisimov

SRI of Cerebrovascular Pathology and Stroke FSBEI HE RNSMU n.a. N.I. Pirogov of RMH

N. S Tsareva

SRI of Cerebrovascular Pathology and Stroke FSBEI HE RNSMU n.a. N.I. Pirogov of RMH

References

  1. Krishnamurthi R.V., Feigin V.L., Forouzanfar M.Hb., Mensah G.A., Connor M., Bennett D.A., MoranA.E., Sacco R.L., Anderson L.M., Truelsen T., O'Donnell M., Venketa-subramanian N., Barker-Collo S., Lawes C.M., Wang W., Shinohara Y., Witt E., Ezzati M., Naghavi M., Murray C. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Global Health. 2013;1(5):259-81.
  2. http://www.eso-stroke.org.
  3. Jauch E.C., Saver J.L., Adams H.P., Bruno A., Connors J.J., Demaerschalk B., Khatri P., McMullan P.W. Jr., Qureshi A.I., Rosenfield K., Scott P.A., Summers D.R., Wang D.Z., Wintermark M., Yonas H. American Heart Association Stroke Council; Council on Car-diovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardi-ology.Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947.
  4. Tissue Plasminogen Activator For Acute Ishemic Stroke. N. Engl. J. Med. 1995;333(24).
  5. Hacke W., Kaste M., Fieschi C., Toni D., Lesaffre E., von Kummer R., Boysen G., Bluhmki E., Höxter G., Mahagne M.H. Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric Stroke The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274(13).
  6. Hacke W., Kaste M., Fieschi C., von Kummer R., Davalos A., Meier D., Larrue V., Bluhmki E., Davis S., Donnan G., Schneider D., Diez-Tejedor E., Trouillas P. Randomised double-blind placebocontrolled trial of thrombolytic therapy with intravenous alteplase in acute is-chaemic stroke (ECASS II). Lancet. 1998;352(9136):1245-51.
  7. Clark W.M., Wissman S., Albers G., Jhamandas J.H., Madden K.P., Hamilton S. Recom-binant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset. The ATLANTIS Study: A Randomized Controlled Trial. JAMA. 1999;282:2019-26.
  8. Hacke W., Kaste M., Bluhmki E., Brozman M., Davalos A., Guidetti D., Larrue V., Lees K.R., Medeghri Z., Machnig T., Schneider D., von Kummer R., Wahlgren N., Toni D. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke. N. Engl. J. Med. 2008;359:1317-29.
  9. Fagan S.C., Morgenstern L.B., Petitta A., Ward R.E., Tilley B.C., Marler J.R., Levine S.R., Broderick J.P., Kwiatkowski T.G., Frankel M., Brott T.G., Walker M.D. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. N!NDS rt-PA Stroke Study Group. Neurology. 1998;50:883-90.
  10. Guzauskas G.F., Boudreau D.M., Villa K.F., Levine S.R., Veenstra D.L. The costeffectiveness of primary stroke centers for acute stroke care. Stroke. 2012;43:1617-23.
  11. Kruyt N.D., Nederkoorn P.J., Dennis M., Leys D., Ringleb P.A., Rudd A.G., Vermeulen M., Stam J., Hacke W., Roos Y.B. Door-to-Needle Time and the Proportion of Patients Receiving !ntravenous Thrombolysis in Acute Ischemic Stroke. Uniform Interpretation and Reporting. Stroke. 2013;44:3249-53.
  12. Скворцова В.И., Голухов Г.Н., Губский Л.В., Шамалов Н.А., Сидоров А.М., Бодыхов М.К., Рамазанов Г.Р., Якимович П.В., Киреев А.С. Системная тромболитическая терапия при ишемическом инсульте; Журн. невропатол. и психиатр. им. С.С. Корсакова. 2006;106(12):24-31.
  13. Скворцова В.И., Голухов Г.Н., Волынский Ю.Д., Губский Л.В., Шамалов Н.А., Кириллов М.Г Высокая эффективность селективного внутриартериального тромбо-лизиса при лечении ишемического инсульта у больных с окклюзией артерий крупного калибра. Журн. невропатологии и психиатрии им. С.С. Корсакова. 2006;106(12):32-40.
  14. Демин Т.В., Сайхунов М.В., Хасанова Д.Р Опыт применения внутривенного тромболизиса при ишемическом инсульте. Неврология, нейропсихиатрия, психосоматика, 2010;1: 42-6.
  15. Домашенко М.А., Максимова М.Ю., Лоскутников М.А., Никонов А.А., Брюхов В.В. и Суслин А.С., Древаль М.В., Коновалов Р.Н. Механизмы реперфузии при внутривенной тромболитической терапии у пациентов с ишемическим инсультом. Неврология, нейропсихиатрия, психосоматика. 2012;4:53-7.
  16. Скворцова В.И., Шамалов Н.А., Анисимов К.В., Рамазанов Г.Р Результаты внедрения тромболитической терапии при ишемическом инсульте в Российской Федерации. Инсульт. Журн. невропатол. и психиатр. им. С.С. Корсакова. 2010;12(2):17-22.
  17. Bray B.D., Campbell J., Cloud G.C., Hoffman A., Tyrrell P.J., Wolfe C.D., Rudd A.G. Bigger, Faster? Associations Between Hospital Thrombolysis Volume and Speed of Thrombolysis Administration in Acute !schemic Stroke. Stroke. 2013;44:3129-35.
  18. Kunisawa S., Kobayashi D., Lee J., Otsubo T., Ikai H., Yokota C., Minematsu K., Imanaka Y. Factors associated with the administration of tissue plasminogen activator for acute ischemic stroke. J. Stroke Cerebrovasc. Dis. 2014;23(4):724-31.
  19. Katzan I.L., Hammer M.D., Hixson E.D., Furlan A.J., Abou-Chebl A., Nadzam D.M. Utilization of !ntravenous Tissue Plasminogen Activator for Acute !schemic Stroke. Arch. Neurol. 2004;61:346-50.
  20. van Wijngaarden J.D., Dirks M., Niessen L.W., Huijsman R., Dippel D.W.J. Do centres with well-developed protocols, training and infrastructure have higher rates of thrombolysis for acute ischaemic stroke? Q. J. Med. 2011; 104:785-91.
  21. van Wijngaarden J.D., Dirks M., Huijsman R., Niessen L.W., Fabbricotti I.N., Dippel D.W. Promoting Acute Thrombolysis for !schaemic Stroke (PRACT!SE) !nvestigators. Hospital rates of thrombolysis for acute ischemic stroke: the influence of organizational culture. Stroke. 2009;40(10):3390-92.
  22. Boode B., Welzen V., Franke C., van Oostenbrugge R. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided. Cerebrovasc. Dis. 2007; 23(4):294-98.
  23. Keskin O., Kalemoglu M., Ulusoy R. A clinic investigation into prehospital and emergency department delays in acute stroke care. Med. Princ. Pract. 2005;14:408-12.
  24. Mosley I., Nicol M., Donnan G., Patrick I., Kerr F., Dewey H. The impact of ambulance practice on acute stroke care. Stroke. 2007;38:2765-70.
  25. Stern E.B., Berman M.E., Thomas J.J., Klassen A.C. Community Education for Stroke Awareness. An Efficacy Study. Stroke. 1999;30:720-23.
  26. Hodgson C., Lindsay P., Rubini F. Can mass media influence emergency department visits for stroke?Stroke. 2007;38:7:2115-22.
  27. Гусев Е.И., Скворцова В.И., Стаховская Л.В., Киликовский В.В., Айриян Н.Ю. Эпидемиология инсульта в России. Consilium medicum. 2003;5(5).
  28. Биденко М.А., Шпрах В.В. Оценка качества оказания медицинской помощи больным мозговым инсультом по данным госпитального регистра в г. Иркутске. Сибирский мед. журн. 2009;2:68-70.
  29. Скворцова В.И., Стаховская Л.В., Лелюк В.Г., Иванова Г.Е., Шамалов Н.А., Губский Л.В., Шеховцова К.В. Становление системы оказания медицинской помощи больным с церебральным инсультом в Российской Федерации. Материалы Всероссийской научно-практической конференции «Совершенствование оказания медицинской помощи больным с сосудистыми заболеваниями». Ярославль, 2011. М., 2011:13-33.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies